VolitionRx Limited Impairment of Long-Lived Assets to be Disposed of
VolitionRx Limited (VNRX) reported Impairment of Long-Lived Assets to be Disposed of of $0 for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf · last filed 2016-03-11
- VolitionRx Limited impairment of long-lived assets to be disposed of for fiscal 2015 was $0.00.
- VolitionRx Limited impairment of long-lived assets to be disposed of for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- VolitionRx Limited impairment of long-lived assets to be disposed of for fiscal 2013 was $350.00K.
- VolitionRx Limited impairment of long-lived assets to be disposed of for fiscal 2012 was $0.00.
| Period end | Impairment of Long-Lived Assets to be Disposed of 12 month |
|---|---|
| 2015-12-31 | $0.00 10-K · filed 2016-03-11 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-11 |
| 2013-12-31 | $350.00K 10-K · filed 2015-03-18 |
| 2012-12-31 | $0.00 10-K · filed 2014-03-28 |
| 2011-12-31 | $0.00 10-K · filed 2013-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |